Skip to main content

NATIXIS ADVISORS, LLC

Position in GSK — GSK plc

CIK 1018331 Boston, MA

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,171,081
+$1,113,305 QoQ
Shares Held
289,414
+13.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#86
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. GSK ranks #13 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GSK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,171,081 289,414
2026-03-31 $14,057,776 254,716
2025-12-31 $9,798,535 199,807
2025-09-30 $15,235,436 352,999
2025-06-30 $13,631,654 354,991
2025-03-31 $14,219,323 367,045
2024-12-31 $11,611,555 343,334
2024-09-30 $20,460,235 500,495
2024-06-30 $16,056,887 417,062
2024-03-31 $16,192,684 377,716
2023-12-31 $12,069,552 325,676
2023-09-30 $10,661,487 294,110
2023-06-30 $8,631,579 242,188
2023-03-31 $7,501,900 210,846
2022-12-31 $5,897,721 167,835
2022-09-30 $6,554,855 222,727
2022-06-30 $15,284,018 357,988
2022-03-31 $13,102,659 306,684
2021-12-31 $10,276,070 237,579
2021-09-30 $10,635,080 283,781
2021-06-30 $10,784,343 276,129
2021-03-31 $9,464,794 270,386
2020-12-31 $11,949,490 331,071
2020-09-30 $17,512,538 474,372
2020-06-30 $19,883,635 497,006
2020-03-31 $23,811,544 640,741